US Patent Issued to HEM PHARMA on Jan. 20 for "Strain of Bifidobacterium animalis subsp. lactis HEM20-01 and composition for treating depression, comprising the same or its culture fluid" (South Korean Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,824, issued on Jan. 20, was assigned to HEM PHARMA INC. (Pohang-si, South Korea).

"Strain of Bifidobacterium animalis subsp. lactis HEM20-01 and composition for treating depression, comprising the same or its culture fluid" was invented by So Young Park (Suwon-si, South Korea) and Yo Sep Ji (Suwon-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a strain of Bifidobacterium animalis subsp. lactis HEM20-01 (KCTC14143BP) and a composition for treating, preventing or alleviating depression, comprising the same.A strain of Bifidobacterium animalis subsp. lactis HEM20-01 (KCTC14143BP) according to an embodim...